MGC received legal permission for the sale of cannabis based medicine for medical use in Australia's new market.
MGC Pharma sells MGC Derma business to strategic partners with a five year supply agreement for MGC Pharma's cannabidiol (CBD) and cosmetics raw material to Cannaglobal products.
THC Global Group Ltd (ASX:THC) has signed a supply agreement for formulated medicinal cannabis products with MGC Pharmaceuticals Ltd (ASX:MXC).Under the Agreement, MGC Pharma will provide THC with an immediate supplementary source of medicinal cannabis products, which will be packaged and made available to patients under the Canndeo brand
- Forums
- ASX - By Stock
- Ann: Production commenced to support 6000 Australian Patients
MGC received legal permission for the sale of cannabis based...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable